Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates
181 VaratharajaluR.GarigeM.LeckeyL
Human umbilical cord-derived mesenchymal stem cells ameliorate skin aging of nude mice through autophagy-mediated anti-senescent mechanism
Get a Quote Vendor Listing Feature your compound alongside our catalog
For brand medications, Novo Nordisks NovoCare and Eli Lillys patient assistance programs offer income-based help